Vopratelimab (MouseIgG2a) is a monoclonal antibody that selectively targets the inducible T-cell co-stimulator (ICOS). The variable region of Vopratelimab (MouseIgG2a) matches that of Vopratelimab, while its constant region is based on the mouse IgG2a sequence. Vopratelimab (MouseIgG2a) promotes anti-tumor immune responses and enhances the efficacy of combination therapy with anti-PD-1.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted